Juxtaglomerular cell tumor

Juxtaglomerular cell tumor
Other names: Reninoma
SpecialtyNephrology/oncology

Juxtaglomerular cell tumor (JCT, JGCT, also reninoma) is an extremely rare kidney tumour of the juxtaglomerular cells, with less than 100 cases reported in literature. This tumor typically secretes renin, hence the former name of reninoma. It often causes severe hypertension that is difficult to control, in adults and children, although among causes of secondary hypertension it is rare. It develops most commonly in young adults, but can be diagnosed much later in life. It is generally considered benign, but its malignant potential is uncertain.[1]

Signs and symptoms

The clinical presentation in the literature indicates hypertension[1]

Pathophysiology

By hypersecretion of renin, JCT causes hypertension, often severe and usually sustained but occasionally paroxysmal,[2] and secondary hyperaldosteronism inducing hypokalemia, though the later can be mild despite high renin.[3] Both of these conditions may be corrected by surgical removal of the tumor.[4] Asymptomatic cases have been reported.[5]

Histopathology

Histological exam shows microscopic characteristics of juxtaglomerular tumor cells

JCT is morphologically characterized by multiple foci malignant mesenchymal epithelioid cells with, often with admixed necrosis, and a perivascular growth pattern. The immunophenotype is rather characteristic, as the neoplastic cells express renin, CD34, smooth muscle actin, CD138, vimentin, collagen IV and is negative for cytokeratins as well as for S100, c-Kit and desmin.[6]

Diagnosis

Clinically, hypertension, especially when severe or poorly controlled, combined with evidence of a kidney tumor via imaging or gross examination suggest a JCT. However, other kidney tumors can cause hypertension by secreting renin. JCTs have a variable appearance and have often being misdiagnosed as renal cell carcinomas; dynamic computed tomography is helpful in the differential diagnosis.[7]

Post-operatively, the presence of renin granules in pathology specimens as well as immunohistochemical analyses could help differentiating this tumor from other primary renal tumors such as hemangiopericytoma, glomus tumor, metanephric adenoma, epithelioid angiomyolipoma, Wilms tumor, solitary fibrous tumor, and some epithelial neoplasms.[6][8]

Management

In terms of treatment we find that a partial nephrectomy is usually done[9]

Prognosis

JCT often is described as benign, however one case of metastasis has been reported, so its malignant potential is uncertain.[1] In most cases the tumor is encapsulated.[10]

History

Juxtaglomerular cell tumor was first described in 1967 in a paper by Robertson et al., and first named by Kihara et al. in 1968. Since then, approximately 100 case reports have been published.[5] Karyotyping of a small number of these tumors revealed a common loss of chromosomes 9 and 11.[1]

References

  1. 1 2 3 4 Capovilla M, Couturier J, Molinié V, Amsellem-Ouazana D, Priollet P, Baumert H, Bruneval P, Vieillefond A (March 2008). "Loss of chromosomes 9 and 11 may be recurrent chromosome imbalances in juxtaglomerular cell tumors". Hum. Pathol. 39 (3): 459–62. doi:10.1016/j.humpath.2007.08.010. PMID 18261631.
  2. ↑ W. Hanna; et al. (April 2, 1979). "Juxtaglomerular cell tumour (reninoma) with paroxysmal hypertension". Can Med Assoc J. 120 (8): 957–9. PMC 1819229. PMID 436071.
  3. ↑ Beaudoin, J.; Périgny M; Têtu B; Lebel M. (2008). "A Patient With A Juxtaglomerular Cell Tumor With Histological Vascular Invasion". Nature Clinical Practice Nephrology. 4 (8): 458–62. doi:10.1038/ncpneph0890. PMID 18654602.
  4. ↑ Wong L, Hsu TH, Perlroth MG, Hofmann LV, Haynes CM, Katznelson L (February 2008). "Reninoma: case report and literature review". J. Hypertens. 26 (2): 368–73. doi:10.1097/HJH.0b013e3282f283f3. PMID 18192852.
  5. 1 2 Naoto Kuroda; et al. (2011). "Review of juxtaglomerular cell tumor with focus on pathobiological aspect". Diagnostic Pathology. 6: 80. doi:10.1186/1746-1596-6-80. PMC 3173291. PMID 21871063.
  6. 1 2 Cucchiari D, Bertuzzi A, Colombo P, De Sanctis R, Faucher E, Fusco N, Pellegrinelli A, Arosio P, Angelini C (May 2013). "Juxtaglomerular cell tumor: multicentric synchronous disease associated with paraneoplastic syndrome". J Clin Oncol. 31 (14): e240–2. doi:10.1200/JCO.2012.43.5545. PMID 23547072.
  7. ↑ Tanabe; et al. (July 2001). "Dynamic computer tomography is useful in the differential diagnosis of juxtaglomerular cell tumor and renal cell carcinoma.Tanab". Hypertens. Res. 24 (4): 331–6. doi:10.1291/hypres.24.331. PMID 11510743.
  8. ↑ Martin SA, Mynderse LA, Lager DJ, Cheville JC; Martin; Lager; Cheville (December 2001). "Juxtaglomerular cell tumor: a clinicopathologic study of four cases and review of the literature". Am. J. Clin. Pathol. 116 (6): 854–63. doi:10.1309/B10J-FKQ5-J7P8-WKU4. PMID 11764074.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  9. ↑ Jiang, Shuangjian; Yang, Yun; Wu, Rongpei; Yang, Qiyun; Zhang, Chi; Tang, Yiming; Mo, Chengqiang (2020-9). "Characterization and Management of Juxtaglomerular Cell Tumor: Analysis of 9 Cases and Literature Review". Balkan Medical Journal. 37 (5): 287–290. doi:10.4274/balkanmedj.galenos.2020.2019.12.79. ISSN 2146-3123. Archived from the original on 17 October 2022. Retrieved 16 October 2022. {{cite journal}}: Check date values in: |date= (help)
  10. ↑ Abbi RK, McVicar M, Teichberg S, Fish L, Kahn E (1993). "Pathologic characterization of a renin-secreting juxtaglomerular cell tumor in a child and review of the pediatric literature". Pediatr Pathol. 13 (4): 443–51. doi:10.3109/15513819309048234. PMID 8372029.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.